Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Phytochemistry ; 198: 113154, 2022 Jun.
Article in English | MEDLINE | ID: mdl-35245525

ABSTRACT

Three undescribed diterpenes including two ent-abietanes, euphomauritanol A, and euphomauritanol B, and one jatrophane, euphomauritanophane A, in addition to eight previously described metabolites were isolated from the MeOH-CH2Cl2 (1:1) extract of the Euphorbia mauritanica. The chemical structures of isolates were established based on the spectroscopic means including FT-IR, HRMS, 1D and 2D NMR. The absolute stereochemistry of the undescribed diterpenes was deduced by experimental and calculated TDDFT-electronic circular dichroism (ECD). The anti-proliferative effects of the isolated diterpenes were evaluated against B16-BL6, Hep G2, and Caco-2. The euphomauritanol A, euphomauritanol B, and euphomauritanophane A significantly inhibited the growth of murine melanoma B16-BL6 cell lines with IC50 10.28, 20.22, and 38.81 µM, respectively with no responses against the other cells. These activities were rationalized by molecular docking of the active compounds in BRAFV600E and MEK1 active sites. Moreover, the in-silico pharmacokinetics predictions by Swiss ADME revealed that the active compounds possessed favorable oral bioavailability and drug-likeness properties.


Subject(s)
Diterpenes , Euphorbia , MAP Kinase Kinase 1 , Melanoma , Proto-Oncogene Proteins B-raf , Animals , Caco-2 Cells , Diterpenes/chemistry , Diterpenes/pharmacology , Egypt , Euphorbia/chemistry , Hep G2 Cells , Humans , MAP Kinase Kinase 1/metabolism , Melanoma/drug therapy , Melanoma/enzymology , Melanoma, Experimental/drug therapy , Melanoma, Experimental/enzymology , Mice , Molecular Docking Simulation , Molecular Structure , Proto-Oncogene Proteins B-raf/metabolism , Spectroscopy, Fourier Transform Infrared
2.
J Enzyme Inhib Med Chem ; 33(1): 1095-1107, 2018 Dec.
Article in English | MEDLINE | ID: mdl-29944015

ABSTRACT

Herein, we report the synthesis of different novel sets of coumarin-6-sulfonamide derivatives bearing different functionalities (4a, b, 8a-d, 11a-d, 13a, b, and 15a-c), and in vitro evaluation of their growth inhibitory activity towards the proliferation of three cancer cell lines; HepG2 (hepatocellular carcinoma), MCF-7 (breast cancer), and Caco-2 (colon cancer). HepG2 cells were the most sensitive cells to the influence of the target coumarins. Compounds 13a and 15a emerged as the most active members against HepG2 cells (IC50 = 3.48 ± 0.28 and 5.03 ± 0.39 µM, respectively). Compounds 13a and 15a were able to induce apoptosis in HepG2 cells, as assured by the upregulation of the Bax and downregulation of the Bcl-2, besides boosting caspase-3 levels. Besides, compound 13a induced a significant increase in the percentage of cells at Pre-G1 by 6.4-folds, with concurrent significant arrest in the G2-M phase by 5.4-folds compared to control. Also, 13a displayed significant increase in the percentage of annexin V-FITC positive apoptotic cells from 1.75-13.76%. Moreover, QSAR models were established to explore the structural requirements controlling the anti-proliferative activities.


Subject(s)
Antineoplastic Agents/chemistry , Antineoplastic Agents/pharmacology , Coumarins/chemistry , Quantitative Structure-Activity Relationship , Sulfonamides/chemistry , Antineoplastic Agents/chemical synthesis , Caco-2 Cells , Cell Cycle/drug effects , Cell Proliferation/drug effects , Coumarins/pharmacology , Dose-Response Relationship, Drug , Drug Screening Assays, Antitumor , Hep G2 Cells , Humans , MCF-7 Cells , Molecular Structure , Sulfonamides/pharmacology
3.
J Clin Pathol ; 58(2): 178-84, 2005 Feb.
Article in English | MEDLINE | ID: mdl-15677539

ABSTRACT

BACKGROUND: Systemic sclerosis (SSc) is a multisystem disease with underlying immune mechanisms. AIMS: To investigate the clinicopathological characteristics of the lesions; immunological alterations in the bronchoalveolar lavage fluid (BALF), peripheral blood, and skin; and correlations between the clinicopathological characteristics and immunological alterations in SSc. MATERIALS/METHODS: Skin biopsies, BALF, and peripheral blood samples were obtained from 19 patients (18 women, one man) with SSc and six age and sex matched healthy controls (HCs). Mononuclear inflammatory cells (MICs), CD4/CD8 cells, tumour necrosis factor alpha (TNFalpha), and interleukin 1beta (IL1-1beta) concentrations were examined in all samples using histological methods, enzyme linked immunosorbent assay, and immunoperoxidase staining. RESULTS: The mean (SD) age of the patients with SSc was 34.8 (2.6) years. Proteinuria, positive rheumatoid factor, and C reactive protein were seen in 15.8%, 26.3%, and 26.3% of patients, respectively. Compared with HCs, there were significantly higher: total MICs (macrophages, lymphocytes), neutrophils, and eosinophils in BALF, blood, and skin (all p<0.05); cytokine concentrations in BALF (TNFalpha, p<0.001; IL-1, p<0.01) and peripheral blood (p<0.01 and p<0.05); and CD8/CD4+ T cells in peripheral blood (p<0.05). Compared with HCs, lesional skin had significantly higher histiocyte cell counts (p<0.05), lower lymphocyte counts (p<0.05), and higher CD4/CD8 ratios (p<0.001). There were significant correlations between cytokine concentrations and CD8+ T cells and forced vital capacity (p<0.001 and p<0.01, respectively). CONCLUSIONS: MICs, CD4/CD8+ cells, and cytokines are altered in SSc. These alterations correlated with the underlying disease process and therefore may have pathogenic, modulatory, and potential prognostic roles in SSc.


Subject(s)
Bronchoalveolar Lavage Fluid/immunology , Interleukin-1/analysis , Leukocytes/immunology , Scleroderma, Systemic/immunology , Skin/immunology , Tumor Necrosis Factor-alpha/analysis , Adult , CD4-CD8 Ratio , CD4-Positive T-Lymphocytes/immunology , CD8-Positive T-Lymphocytes/immunology , Eosinophils/immunology , Female , Humans , Interleukin-1/blood , Leukocyte Count , Macrophages/immunology , Male , Neutrophils/immunology , Scleroderma, Systemic/blood , Scleroderma, Systemic/pathology , Skin/pathology
4.
Phytochemistry ; 60(4): 385-7, 2002 Jun.
Article in English | MEDLINE | ID: mdl-12031430

ABSTRACT

A benzoquinone, named alopecuquinone, was isolated from the ethanol extract of the inflorescences of Cyperus alopecuroides. Its structure was primarily elucidated by spectroscopic analysis including 1H, 13C NMR, APT, HMQC, 1H-1H COSY and CIMS. The known flavonoids, vicenin 2, orientin, diosmetin, quercetin 3,3'-dimethyl ether and its 3,4'-dimethyl ether, were also isolated and characterized. The ethanol extract of the plant material showed moderate estrogenic activity using a strain of Saccharomyces cerevisiae.


Subject(s)
Benzoquinones/chemistry , Benzoquinones/isolation & purification , Cyperus/chemistry , Flavonoids/chemistry , Flavonoids/isolation & purification , Isoflavones , Magnoliopsida/chemistry , Benzoquinones/pharmacology , Egypt , Estrogens, Non-Steroidal/chemistry , Estrogens, Non-Steroidal/isolation & purification , Estrogens, Non-Steroidal/pharmacology , Flavonoids/pharmacology , Galactosidases/metabolism , Humans , Mass Spectrometry/methods , Nuclear Magnetic Resonance, Biomolecular/methods , Oils, Volatile/analysis , Oils, Volatile/chemistry , Phytoestrogens , Plant Extracts , Plant Preparations , Plants, Medicinal , Plasmids/biosynthesis , Plasmids/metabolism , Receptors, Estrogen/metabolism , Saccharomyces cerevisiae/drug effects , Saccharomyces cerevisiae/enzymology , Spectrophotometry, Ultraviolet
SELECTION OF CITATIONS
SEARCH DETAIL
...